- Drug Pipelines
- April 2025
- 400 Pages
Global
From €4625EUR$5,000USD£3,859GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1850EUR$2,000USD£1,544GBP
- Report
- January 2024
- 120 Pages
Global
From €7353EUR$7,950USD£6,137GBP
- Report
- June 2025
- 400 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- June 2025
- 400 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- June 2025
- 300 Pages
Asia Pacific
From €3579EUR$3,869USD£2,986GBP
- Report
- June 2025
- 400 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- June 2025
- 400 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- August 2024
- 200 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- July 2024
- 200 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- June 2024
- 140 Pages
Europe
From €3579EUR$3,869USD£2,986GBP
- Report
- April 2023
- 147 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- July 2024
- 171 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- May 2023
- 120 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- August 2025
- 147 Pages
Global
From €3653EUR$3,950USD£3,049GBP
- Report
- August 2025
- 154 Pages
Global
From €3653EUR$3,950USD£3,049GBP
- Report
- June 2025
- 142 Pages
Global
From €3653EUR$3,950USD£3,049GBP
- Report
- May 2025
- 175 Pages
Europe
From €3237EUR$3,500USD£2,702GBP
- Report
- April 2025
- 199 Pages
Global
From €4620EUR$4,995USD£3,856GBP
- Report
- March 2025
- 240 Pages
Global
From €4620EUR$4,995USD£3,856GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more